| Introduction | For Patients | For Science | For Society | Looking Ahead People Powering Science Great science starts with people. The People Powering Science campaign steps behind the breakthroughs to meet the scientists, researchers and innovators who make them possible – and to share, in their own words, how they found their way to science and what keeps them curious. The campaign highlights the personal journeys, motivations and proudest moments of the people who power CSL’s research and development (R&D). The initial series features ten scientists across our R&D hubs in Waltham, King of Prussia, Maidenhead, Zurich and Melbourne, with more stories to be added in the coming year. People Powering Science turns abstract science into something deeply human like the stories of Hanna Sundström, who followed a single molecule she helped discover in the lab all the way through to patients, and Christopher Dumayne, whose own battle with leukaemia taught him that: “Science isn’t abstract. It’s hope made real.” People Powering Science demonstrates that, behind every therapy, is a person driven by curiosity, persistence and the belief that science can change lives. Creating Promising Futures At CSL, investing in people means creating opportunities that extend beyond the workplace. Now in its fifth year, the Promising Futures Scholarship program reflects CSL's commitment to support education, development and future opportunities for employees and their families. This year, CSL awarded $135,000 USD in scholarship funding to students pursuing technical training, vocational programs, undergraduate studies and graduate education during the 2026–27 academic year. The scholarship program is administered by International Scholarship & Tuition Services (ISTS), an independent organisation that reviews applications and selects recipients through a competitive process. Science isn’t abstract. It’s hope made real. Christopher Dumayne, employee and patient with leukaemia Gender Composition All Employees (%)* Employees Worldwide By Region (%)* *Figures correct as of 30 June 2026. 32 | CSL IMPACT REPORT 2026
RkJQdWJsaXNoZXIy MjE2NDg3